Boardroom Alpha
Start trial
8-K primary document
ARDT · Current Report (Form 8-K) · Filed November 18, 2025

Ardent Health Inc — 8-K exhibit

ex99-111825pressrelease.htm
Ardent Health Inc on Boardroom Alpha
EX99 - 11.18.25 Press Release
EXHIBIT 99
ardtlogoa.jpg
Ardent Health Announces $50 Million Share Repurchase
Program Authorization
BRENTWOOD, Tenn. (Nov. 18, 2025) – Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing
mid-sized urban communities across the U.S., today announced its Board of Directors has authorized a share
repurchase program of up to $50 million. 
“This authorization reflects our conviction in the fundamental strength of Ardent’s business and our ability to
deliver sustained, long-term shareholder value,” said Marty Bonick, President and Chief Executive Officer. “With
a strong balance sheet and significant financial capacity, we are well positioned to act decisively when market
conditions present attractive opportunities. The program enhances our flexibility to deploy capital in ways that
align with our view of intrinsic value, while continuing to invest in strategic growth initiatives that advance our
mission and expand our reach.”
The program will be funded from existing cash resources and does not impact Ardent’s ability to pursue strategic
growth opportunities, including mergers and acquisitions, given its strong liquidity position with $609 million of
cash and a lease-adjusted net leverage of 2.5x as of the end of Q3 2025.
About Ardent Health
Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across
the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate
about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care
through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 employed and
affiliated providers across six states. For more information, please visit ardenthealth.com.
Investor Contact:
Dave Styblo, CFA
Investor.Relations@ardenthealth.com
(615) 296-3016
Media Contact:
Rebecca Kirkham
rebecca.kirkham@ardenthealth.com
(615) 296-3000
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer